Clinical trials
Phase 2 Hallucinations trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Enrolling by invitation | 1 |
| Recruiting | 1 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ACADIA Pharmaceuticals Inc. | 2 |
| Axovant Sciences Ltd. | 2 |
| MapLight Therapeutics | 2 |
| Novartis Pharmaceuticals | 2 |
| AstraZeneca | 1 |
| Greater Manchester Mental Health NHS Foundation Trust | 1 |
| New York State Psychiatric Institute | 1 |
| University Hospital Tuebingen | 1 |
| University Hospital, Caen | 1 |
| University Medical Center Groningen | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hallucinations | 16 |
| Psychotic Disorders | 8 |
| Schizophrenia | 8 |
| Mental Disorders | 5 |
| Alzheimer Disease | 3 |
| Dementia | 3 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Lewy Body Disease | 2 |
| Nervous System Diseases | 2 |
Trials
Showing 26 to 16 of 16. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.